Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations

被引:39
作者
Li, Quan [1 ,2 ]
Cao, Zanxia [3 ]
Rahman, Proton [1 ]
机构
[1] Mem Univ, Fac Med, Dept Med, St John, NF, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2020年 / 8卷 / 08期
关键词
angiotensin-converting enzyme 2; COVID-19; ethnic variation; gene expression; molecular dynamics simulation; SARS-CoV-2; GPU NODES; PROTEIN; BANG; ACE2;
D O I
10.1002/mgg3.1344
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background There appears to be large regional variation for susceptibility, severity, and mortality for COVID-19 infections. Numerous potential factors could explain the wide variability in the number of infections and death among the countries. We examined genetic differences in the human angiotensin-converting enzyme 2 (hACE2) gene, as its receptor serves as a cellular entry for SARS-CoV-2. At present, there is a paucity of data regarding the differences for ACE2 polymorphisms and expression levels between ethnicities. Methods We compared the allele frequency of mutations between European and East Asians. Molecular dynamic simulation were performed to investigate the influences of significant mutant on protein structure. The binding free energies were calculated between S protein and hACE2. We also examined hACE2 gene expression in eight global populations from HapMap3. Results Four missense mutations showed significant minor allele frequency difference between Asians and Caucasians. Molecular dynamic demonstrated that two of these variants (K26R and I468V) may affect binding characteristics between S protein of the virus and hACE2 receptor. We also noted marginal differences in gene expression for some populations in HapMap3 as compared to the Chinese population. Conclusion Our studies reveal subtle changes in the genetics of hACE2 between human populations, but the magnitude of the difference was small and the significance is not clear in the absence of further in vitro and functional studies.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
    Lutz, Cathleen
    Maher, Leigh
    Lee, Charles
    Kang, Wonyoung
    HUMAN GENOMICS, 2020, 14 (01)
  • [42] Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
    Han, Kun
    Blair, Robert, V
    Iwanaga, Naoki
    Liu, Fengming
    Russell-Lodrigue, Kasi E.
    Qin, Zhongnan
    Midkiff, Cecily C.
    Golden, Nadia A.
    Doyle-Meyers, Lara A.
    Kabir, Mohammad E.
    Chandler, Kristin E.
    Cutrera, Kellie L.
    Ren, Mi
    Monjure, Christopher J.
    Lehmicke, Gabrielle
    Fischer, Tracy
    Beddingfield, Brandon
    Wanek, Alanna G.
    Birnbaum, Angela
    Maness, Nicholas J.
    Roy, Chad J.
    Datta, Prasun K.
    Rappaport, Jay
    Kolls, Jay K.
    Qin, Xuebin
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2021, 64 (01) : 79 - 88
  • [43] Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
    Alabsi, Sarah
    Dhole, Atharva
    Hozayen, Sameh
    Chapman, Scott A.
    MICROORGANISMS, 2023, 11 (03)
  • [44] Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity
    Saulnier, Nathalie M.
    Thorne, Devyn M.
    Bablu, Fariha E.
    Suzuki, Alessia M.
    Khan, Rafa L.
    Oliveira, Katelin X.
    Suzuki, Yuichiro J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 761
  • [45] Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
    Murray, Eleanor
    Tomaszewski, Maciej
    Guzik, Tomasz J.
    CARDIOVASCULAR RESEARCH, 2020, 116 (07) : E87 - E89
  • [46] A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
    Xiao, Tianshu
    Lu, Jianming
    Zhang, Jun
    Johnson, Rebecca I.
    McKay, Lindsay G. A.
    Storm, Nadia
    Lavine, Christy L.
    Peng, Hanqin
    Cai, Yongfei
    Rits-Volloch, Sophia
    Lu, Shen
    Quinlan, Brian D.
    Farzan, Michael
    Seaman, Michael S.
    Griffiths, Anthony
    Chen, Bing
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2021, 28 (02) : 202 - +
  • [47] Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
    Imai, Yumiko
    Kuba, Keiji
    Ohto-Nakanishi, Takayo
    Penninger, Josef M.
    CIRCULATION JOURNAL, 2010, 74 (03) : 405 - 410
  • [48] Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India
    Patnaik, Manisha
    Pati, Pallabi
    Swain, Surendra N.
    Mohapatra, Manoj K.
    Dwibedi, Bhagirathi
    Kar, Shantanu K.
    Ranjit, Manoranjan
    ANNALS OF HUMAN BIOLOGY, 2014, 41 (02) : 143 - 150
  • [49] Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
    Kriszta, Gabor
    Kriszta, Zsofia
    Vancsa, Szilard
    Hegyi, Peter Jeno
    Frim, Levente
    Eross, Balint
    Hegyi, Peter
    Petho, Gabor
    Pinter, Erika
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α-converting enzyme
    Iwata, Michikado
    Enciso, Jorge E. Silva
    Greenberg, Barry H.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 297 (05): : C1318 - C1329